Difference between revisions of "Category:TRK inhibitors"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m
m
 
Line 1: Line 1:
 
A class of drugs that inhibit tropomyosin receptor kinase (Trk). The first targeted drug in this class is designed to inhibit NTRK fusions.
 
A class of drugs that inhibit tropomyosin receptor kinase (Trk). The first targeted drug in this class is designed to inhibit NTRK fusions.
  
[[Category: Kinase inhibitors]]
+
[[Category:Tyrosine kinase inhibitors]]

Latest revision as of 22:26, 22 January 2021

A class of drugs that inhibit tropomyosin receptor kinase (Trk). The first targeted drug in this class is designed to inhibit NTRK fusions.

Pages in category "TRK inhibitors"

The following 4 pages are in this category, out of 4 total.